Citius Pharmaceuticals Statistics
NASDAQ: CTXRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.5085+0.0113 (+2.27%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Citius Pharmaceuticals by the numbers
Citius Pharmaceuticals has a market capitalization of $14.0 million based on 27.45M shares outstanding. With trailing EPS of $-1.75, Citius Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 1.6% below its 50-day average and 20.1% below its 200-day average.
Average daily trading volume is 275.44K shares, or about $140,064 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CTXR valuation vs. peer median
| Metric | CTXR | Peer median | Difference |
|---|---|---|---|
| Market cap | $13.96M | $13.63M | +2% |
| Avg. volume | 275.44K | 259.61K | +6% |
Peer median across 8 companies: BYSI, ACTU, NCEL, TVRD, CNTX, CELU, BOLT, NEUP.
Valuation
- Market cap
- $13.96M
- EPS (TTM)
- $-1.75
- Shares outstanding
- 27.45M
Price and trading
- Previous close
- 0.4972
- Open
- 0.481
- Day range
- 0.4805 – 0.5136
- 52-week range
- 0.37 – 1.54
- 52-week change
- -55.39%
- 50-day moving average
- 0.5168
- 200-day moving average
- 0.6366
- Beta
- —
- Volume
- 183.70K
- Average volume
- 275.44K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Dec 22, 2026
Additional statistics
- Market Cap
- 13.96M
- Forward Pe
- -0.35
- Eps
- -1.75
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 1.54
- Week52 Low
- 0.37
- Avg Volume
- 275.44K
- Shares Outstanding
- 27.45M
- Ma50
- 0.52
- Ma200
- 0.64
- Earnings Date
- Dec 22, 2026
- Pct From52w High
- -66.98%
- Pct From52w Low
- 37.43%